Michael King, JMP Securities senior analyst, weighs in on the biotech sector as President-elect Donald Trump puts the pharmaceutical industry in his cross hairs, calling it "disastrous."
CNBC's Bob Pisani and Art Cashin, of UBS, discuss the market’s reaction to President-elect Donald Trump’s first news conference since Election Day.
*Japan's consumer prices fall for nine straight months. TOKYO, Jan 11- Aeon Co posted a 51 percent jump in its third-quarter operating profit as brisk business at supermarkets, drug stores and discount outlets helped the biggest retailer by sales in Japan offset losses at its general merchandise stores. Operating profit for quarter ended Nov. 30 was 13 billion...
Mylan CEO Heather Bresch speaks to CNBC's Meg Tirrell about the future of EpiPen pricing under President-elect Donald Trump as he pushes to bring drug prices down.
Mylan CEO Heather Bresch speaks to CNBC's Meg Tirrell about the future of EpiPen pricing.
CNBC's Meg Tirrell speaks with Express Scripts President & CEO Tim Wentworth on pharmacy benefit managers and drug pricing pressure.
Valeant CEO Joseph Papa speaks to CNBC's Meg Tirrell about the company's turnaround process and drug price increases.
Johnson & Johnson CEO Alex Gorsky speaks to CNBC's Meg Tirrell about his company's expectations for 2017, Donald Trump's impact on the drug industry and potential M&A plans.
A judge ruling blocks Sanofi and partner Regeneron from selling their cholesterol drug, which is a victory for Amgen. CNBC's Meg Tirrell reports.
CNBC's Meg Tirrell reports on how first responders deal with emergency opioid overdose calls, and potential headwinds.
CNBC's Meg Tirrell reports on how high drug prices are limiting access to life-saving drugs such as Naloxone.
CNBC's Meg Tirrell reports the latest on the war on drug prices as several drugs are seeing their prices hiked since the start of the year.
CNBC's Meg Tirrell reports that one analyst is raising a red flag on Biogen due to the incredibly high price of a new drug to treat a rare genetic disease in children.
So-called "superbugs" "threaten the achievements of modern medicine," according to the World Health Organization.
CNBC's Meg Tirrell reports on what Donald Trump's push to lower drug prices may mean for the pharmaceutical industry.
CNBC's Meg Tirrell speaks to Acorda Therapeutics CEO Ron Cohen about Trump's comments against drug prices, and the current state of the biotech industry.
CNBC's Dominic Chu reports the latest on DOJ charges against Heritage Pharmaceuticals executives involving a generic drug pricing scheme.
Short-seller Andrew Left, Citron Research, discusses his tweet directing Donald Trump's attention towards Express Scripts, and his other shorts in the pharmaceutical space.
Short-seller Andrew Left, Citron Research, explains why Express Scripts is the "Philidor of the pharma industry," referring to Philidor Rx Services' alleged misconduct with Valeant Pharmaceuticals.
Shares of Express Scripts plunge following short-seller Andrew Left's series of tweets taking aim at the company. CNBC's Meg Tirrell reports.